Lilly Endowment Inc - Jun 7, 2021 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role
10%+ Owner
Signature
/s/Diane M. Stenson, Vice President & Treasurer, on behalf of Lilly Endowment Inc.
Stock symbol
LLY
Transactions as of
Jun 7, 2021
Transactions value $
-$51,685,008
Form type
4
Date filed
6/8/2021, 03:16 PM
Previous filing
May 25, 2021
Next filing
Jun 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction LLY Common Stock Sale -$2.43 M -11.1 K -0.01% $219.09 110 M Jun 7, 2021 Direct F1
transaction LLY Common Stock Sale -$1.24 M -5.63 K -0.01% $220.36 110 M Jun 7, 2021 Direct F2
transaction LLY Common Stock Sale -$3.23 M -14.6 K -0.01% $221.12 110 M Jun 7, 2021 Direct F3
transaction LLY Common Stock Sale -$6.56 M -29.5 K -0.03% $222.40 110 M Jun 7, 2021 Direct F4
transaction LLY Common Stock Sale -$10.4 M -46.7 K -0.04% $223.17 110 M Jun 7, 2021 Direct F5
transaction LLY Common Stock Sale -$7.55 M -33.6 K -0.03% $224.27 110 M Jun 7, 2021 Direct F6
transaction LLY Common Stock Sale -$4.77 M -21.2 K -0.02% $225.17 110 M Jun 7, 2021 Direct F7
transaction LLY Common Stock Sale -$2.41 M -10.6 K -0.01% $226.33 110 M Jun 7, 2021 Direct F8
transaction LLY Common Stock Sale -$2.28 M -10 K -0.01% $227.27 110 M Jun 7, 2021 Direct F9
transaction LLY Common Stock Sale -$1.53 M -6.7 K -0.01% $228.38 110 M Jun 7, 2021 Direct F10
transaction LLY Common Stock Sale -$3.97 M -17.3 K -0.02% $229.46 110 M Jun 7, 2021 Direct F11
transaction LLY Common Stock Sale -$3.48 M -15.1 K -0.01% $230.14 110 M Jun 7, 2021 Direct F12
transaction LLY Common Stock Sale -$1.43 M -6.16 K -0.01% $231.36 110 M Jun 7, 2021 Direct F13
transaction LLY Common Stock Sale -$255 K -1.1 K 0% $232.03 110 M Jun 7, 2021 Direct F14
transaction LLY Common Stock Sale -$140 K -600 0% $233.23 110 M Jun 7, 2021 Direct F15

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $218.60 to $219.41, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), and (15) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.6005 to $220.60, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.61 to $221.54, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.7003 to $222.70, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.73 to $223.7293, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.743 to $224.74, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.7442 to $225.73, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.7467 to $226.74, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.79 to $227.777, inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.83 to $228.8247, inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.83 to $229.82, inclusive.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.85 to $230.79, inclusive.
F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.87 to $231.86, inclusive.
F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.89 to $232.88, inclusive.
F15 The price reported in Column 4 is a weighted average price. These shares were sold at prices of $232.91 and $233.29.